Bayforest Capital »

Beam Therapeutics shares owned by Bayforest Capital

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Bayforest Capital from 13F filings

Historical chart of Bayforest Capital investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Bayforest Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Bayforest Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $114k 4.7k 24.27

More positions owned by Bayforest Capital

Southwest Gas Corporation (SWX)
New York Times Cl A (NYT)
Best Buy (BBY)
Telefonaktiebolaget Lm Erics Adr B Sek 10 (ERIC)
First Solar (FSLR)
Sony Group Corp Sponsored Adr (SONY)
Kohl's Corporation (KSS)
Moderna (MRNA)
General Motors Company (GM)
Key (KEY)
Hubspot (HUBS)
Tandem Diabetes Care Com New (TNDM)
Peloton Interactive Cl A Com (PTON)
Solaredge Technologies (SEDG)
Expedia Group Com New (EXPE)

View all positions for Bayforest Capital

Top funds holding Beam Therapeutics

ARK Investment Management
FMR
Farallon Capital Management
Vanguard Group
BlackRock
State Street Corporation
Arch Venture Corp
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Kynam Capital Management
Geode Capital Management
MWG Management
Dimensional Fund Advisors
Ubs Global Asset Management Americas
Casdin Capital

View all funds holding Beam Therapeutics